Crossmark

Screening marine algae metabolites as high-affinity inhibitors of SARS-CoV-2 main protease (3CLpro): an in silico analysis to identify novel drug candidates to combat COVID-19 pandemic

Crossref DOI link: https://doi.org/10.1186/s13765-020-00564-4

Published Online: 2020-11-21

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Muteeb, Ghazala

Alshoaibi, Adil

Aatif, Mohammad

Rehman, Md. Tabish

Qayyum, M. Zuhaib
Funding

Funding for this research was provided by:

King Faisal University (IFT20066)
License Information

Text and Data Mining valid from 2020-11-21

Version of Record valid from 2020-11-21
More Information

Article History

Received: 17 September 2020

Accepted: 7 November 2020

First Online: 21 November 2020

Ethics approval and Consent to participate

: Not applicable. All the authors have participated in this study.

: All the authors agree to the present form of the article and approve it for publication.

: All the authors declare that there is no competing interest that are relevant to the content of this article.

Document is current

Any future updates will be listed below